Pelvital raises $2.3m to advance commercialisation of Flyte device
Pelvital’s Flyte device is approved by the US FDA to treat stress urinary incontinence (SUI) and weakened pelvic floor muscles.
Pelvital’s Flyte device is approved by the US FDA to treat stress urinary incontinence (SUI) and weakened pelvic floor muscles.
The observational study will assess the clinical and workflow benefits of using Hyperfine’s Swoop system in detecting amyloid abnormalities in Alzheimer’s patients.
The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare,...
Acarix starts clinical workflow study for its AI-powered cardiac diagnostic
MMI secures FDA approval for Symani Surgical System
Cleerly touts new data for AI cardiovascular software
Avicenna.AI wins two FDA clearances for AI tools in CT scans